Epidemiology of alcohol and medication as aids to sleep in early adulthood

Sleep
E O JohnsonN Breslau

Abstract

In a representative sample of adults 18-45 years of age, this study addressed three questions about the use of sleep aids in the general population: (1) what are the past-year prevalences of the use of alcohol, over-the-counter medication and prescription medication to facilitate sleep? (2) among those who use these substances for sleep problems, what are the patterns of use? and (3) are there social factors, independent of sleep characteristics, that increase the likelihood of alcohol and medication use to aid sleep? The 1996 Detroit Area Survey was a random-digit-dial, computer-assisted survey of a representative sample of 2,181 adults ages 18-45 in the Detroit primary metropolitan statistical area. Eligible household response rate was 86.8%. In the general population, use of alcohol and medication as sleep aids in the past year was found to be fairly common: 13% used alcohol, 18% used medications and 5% used both. The prevalence of any substance use to aid sleep was 26%. The duration of use was short for the majority of users, less than 1 week. However, duration of use was greater for the majority of those using prescription sleep aids. A substantial minority of users report regular use lasting longer than 1 month: 15%, 9%, ...Continue Reading

Citations

Feb 24, 2006·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Michael D Stein, Peter D Friedmann
Oct 21, 2006·BMC Health Services Research·Daniel A HandelChristopher J Lindsell
Jun 4, 2008·Journal of Psychiatric Practice·Heather L ShibleyLynn M Veatch
May 19, 2012·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Pierce GeogheganBrian A Lawlor
Oct 2, 2012·Neurologia i neurochirurgia polska·Beata Labuz-RoszakMichał Skrzypek
May 29, 2015·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Emily E HartwellLara A Ray
Sep 4, 2015·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Amanda LeggettKara Zivin
May 4, 2017·International Journal of Clinical Pharmacy·Olufunmilola AbrahamSteven M Albert
Jul 7, 2018·The Journal of International Medical Research·Amanda N WilkinsonAvelino C Verceles
Aug 29, 2002·American Journal of Public Health·Mark D EisnerPaul D Blanc
Feb 3, 2006·The American Journal of Drug and Alcohol Abuse·David TeplinMeghan Tyrrell
May 31, 2008·BMC Health Services Research·Arne FetveitBjørn Bjorvatn
Jan 1, 2002·Expert Review of Neurotherapeutics·Melanie K Means, Jack D Edinger
Jun 4, 2011·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lucie CasaultSébastien Simard
Nov 5, 2013·Anaesthesia and Intensive Care·K Y LeeL A Tse
Jul 1, 2014·Alcoholism, Clinical and Experimental Research·Brant P HaslerDuncan B Clark
Oct 21, 2016·Alcoholism, Clinical and Experimental Research·Subhajit ChakravortyKirk J Brower
Mar 7, 2017·The International Journal of Pharmacy Practice·Olufunmilola AbrahamSteven M Albert
Jun 25, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Ian M Colrain
Mar 3, 2020·Journal of Women's Health·Fiona C BakerBrant P Hasler
Apr 27, 2000·Research in Nursing & Health·J A FloydJ J Janisse
Jan 5, 2006·Behavioral Sleep Medicine·H Heith Durrence, Kenneth L Lichstein
Nov 23, 2007·Journal of Addictive Diseases·J Todd ArnedtKirk J Brower
Sep 30, 2009·Behavioral Sleep Medicine·Børge SivertsenSimon Overland
Feb 19, 2015·Frontiers in Behavioral Neuroscience·Joshua J Gamsby, Danielle Gulick
Jun 12, 2013·Postgraduate Medicine·Joseph A LiebermanSharon Paik
May 7, 2014·International Journal of Geriatric Psychiatry·Sarah L CanhamAdam P Spira
Apr 30, 2005·Nature Reviews. Neuroscience·Russell G Foster, Katharina Wulff
Sep 9, 2009·Journal of Sleep Research·Leila Tarokh, Mary A Carskadon
Jul 11, 2002·The Journal of Head Trauma Rehabilitation·Lora Thaxton, Mary Ann Myers
Feb 14, 2003·Current Neurology and Neuroscience Reports·Timothy Roehrs, Thomas Roth
Mar 1, 2005·Industrial Health·Arnaud MetlaineDominique Choudat
Sep 15, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Timothy Roehrs, Thomas Roth
Dec 25, 2009·Chronobiology International·Kimberly Burkhart, James R Phelps
Jun 14, 2014·Behavioral Sleep Medicine·Lisa M FucitoNancy S Redeker
Jul 20, 2019·Journal of Psychoactive Drugs·Brianna R AltmanM Earleywine
Aug 10, 2007·Neuroscience Bulletin·Lin Zhang, Zhong-Xin Zhao
Apr 22, 2004·Alcoholism, Clinical and Experimental Research·Maria M WongRobert A Zucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.